BA
EW icon

Bluesphere Advisors’s Edwards Lifesciences EW Stock Holding History

Bluesphere Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,081
Closed -$245K – 87
2022
Q1 		$245K Hold
2,081
– – 0.21% 82
2021
Q4 		$270K Hold
2,081
– – 0.22% 74
2021
Q3 		$236K Hold
2,081
– – 0.23% 75
2021
Q2 		$216K Sell
2,081
-1,369
-40% -$129K 0.19% 85
2021
Q1 		$289K Hold
3,450
– – 0.26% 67
2020
Q4 		$314K Buy
+3,450
New +$286K 0.34% 56

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bluesphere Advisors's EW Position: Q2 2022 in Review

Bluesphere Advisors sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 2,081 shares — an estimated $245K sold.

Bluesphere Advisors first reported a position in EW in Q4 2020 and held it in 6 quarters. The position peaked at $314K in Q4 2020. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Bluesphere Advisors reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Bluesphere Advisors sold 2,081 Edwards Lifesciences shares in Q2 2022, an estimated $245K.
  • Bluesphere Advisors first reported a position in Edwards Lifesciences in Q4 2020 and held it in 6 quarters.
  • Bluesphere Advisors's Edwards Lifesciences position peaked at $314K in Q4 2020.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Bluesphere Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.